Arcus Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Arcus Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,453	Closed	-$723K	–	133
2025 Q1	$723K	Buy	+1,453	New	+$787K	0.29%	59
2024 Q1	–	Sell	-1,093	Closed	-$580K	–	120
2023 Q4	$580K	Buy	+1,093	New	+$529K	0.2%	59
2023 Q3	–	Sell	-1,429	Closed	-$746K	–	133
2023 Q2	$746K	Hold	1,429	–	–	0.22%	50
2023 Q1	$824K	Buy	1,429 +611	+75%	+$344K	0.28%	46
2022 Q4	$451K	Sell	818 -1,325	-62%	-$702K	0.18%	57
2022 Q3	$1.09M	Buy	2,143 +694	+48%	+$388K	0.45%	37
2022 Q2	$787K	Sell	1,449 -7	-0.5%	-$3.85K	0.34%	43
2022 Q1	$860K	Sell	1,456 -6	-0.4%	-$3.45K	0.31%	44
2021 Q4	$976K	Buy	1,462 +665	+83%	+$415K	0.33%	38
2021 Q3	$455K	Buy	+797	New	+$437K	0.17%	59

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Arcus Capital Partners's TMO Position: Q2 2025 in Review

Arcus Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 1,453 shares — an estimated $723K sold.

Arcus Capital Partners first reported a position in TMO in Q3 2021 and held it in 10 quarters. The position peaked at $1.09M in Q3 2022. 2,458 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Arcus Capital Partners reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Arcus Capital Partners sold 1,453 Thermo Fisher Scientific shares in Q2 2025, an estimated $723K.
Arcus Capital Partners first reported a position in Thermo Fisher Scientific in Q3 2021 and held it in 10 quarters.
Arcus Capital Partners's Thermo Fisher Scientific position peaked at $1.09M in Q3 2022.
2,458 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Arcus Capital Partners's 13F filing for Q2 2025, filed 29 Jul 2025.